KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) Inventory Average (2019 - 2025)

Takeda Pharmaceutical has reported Inventory Average over the past 7 years, most recently at $8.1 billion for Q1 2025.

  • For Q1 2025, Inventory Average rose 3.34% year-over-year to $8.1 billion; the TTM value through Mar 2025 reached $8.1 billion, up 3.34%, while the annual FY2026 figure was $8.6 billion, 6.9% up from the prior year.
  • Inventory Average was $8.1 billion for Q1 2025 at Takeda Pharmaceutical, up from $7.8 billion in the prior quarter.
  • Across five years, Inventory Average topped out at $8.1 billion in Q1 2025 and bottomed at $7.0 billion in Q1 2021.
  • The 5-year median for Inventory Average is $7.4 billion (2023), against an average of $7.5 billion.
  • Year-over-year, Inventory Average decreased 8.03% in 2021 and then grew 5.56% in 2024.
  • Over 5 years, Inventory Average stood at $7.0 billion in 2021, then rose by 2.59% to $7.2 billion in 2022, then rose by 2.32% to $7.4 billion in 2023, then grew by 5.56% to $7.8 billion in 2024, then rose by 3.34% to $8.1 billion in 2025.
  • The last three reported values for Inventory Average were $8.1 billion (Q1 2025), $7.8 billion (Q1 2024), and $7.4 billion (Q1 2023) per Business Quant data.